PDB Short entry for 3F66 HEADER TRANSFERASE 05-NOV-08 3F66 TITLE HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1052-1349; COMPND 5 SYNONYM: HGF RECEPTOR, SCATTER FACTOR RECEPTOR, SF RECEPTOR, HGF/SF COMPND 6 RECEPTOR, MET PROTO-ONCOGENE TYROSINE KINASE, C-MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS C-MET, PROTEIN KINASE, QUINOXALINE, ALTERNATIVE SPLICING; ATP- KEYWDS 2 BINDING; CHROMOSOMAL REARRANGEMENT; DISEASE MUTATION; GLYCOPROTEIN; KEYWDS 3 KINASE; MEMBRANE; NUCLEOTIDE-BINDING; PHOSPHOPROTEIN; POLYMORPHISM; KEYWDS 4 PROTO-ONCOGENE; RECEPTOR; REPEAT; SIGNAL; TRANSFERASE; KEYWDS 5 TRANSMEMBRANE; TYROSINE-PROTEIN KINASE., TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.MEIER,T.CESKA REVDAT 4 27-DEC-23 3F66 1 REMARK REVDAT 3 25-AUG-09 3F66 1 REMARK REVDAT 2 06-JAN-09 3F66 1 JRNL REVDAT 1 23-DEC-08 3F66 0 JRNL AUTH J.PORTER,S.LUMB,F.LECOMTE,J.REUBERSON,A.FOLEY,M.CALMIANO, JRNL AUTH 2 K.LE RICHE,H.EDWARDS,J.DELGADO,R.J.FRANKLIN, JRNL AUTH 3 J.M.GASCON-SIMORTE,A.MALONEY,C.MEIER,M.BATCHELOR JRNL TITL DISCOVERY OF A NOVEL SERIES OF QUINOXALINES AS INHIBITORS OF JRNL TITL 2 C-MET KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 397 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19059779 JRNL DOI 10.1016/J.BMCL.2008.11.062 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 104583 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3235 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 REFLECTION IN BIN (WORKING SET) : 5217 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4469 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 87 REMARK 3 SOLVENT ATOMS : 453 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.071 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.071 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.143 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.974 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4833 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4423 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6569 ; 1.682 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10293 ; 1.267 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 587 ; 5.981 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 201 ;31.266 ;22.935 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 828 ;14.409 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;17.446 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 717 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5319 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1014 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1026 ; 0.220 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4433 ; 0.205 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2355 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2572 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 350 ; 0.179 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 2 ; 0.346 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 1 ; 0.229 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.187 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 62 ; 0.313 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.193 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2907 ; 4.888 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1171 ; 3.064 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4732 ; 6.142 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1990 ; 8.125 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1837 ;10.096 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3F66 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050195. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 107820 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 24.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : 0.03600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.5900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51600 REMARK 200 R SYM FOR SHELL (I) : 0.36500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.010 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 LYS A 1103 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 HIS B 1052 REMARK 465 ILE B 1053 REMARK 465 ASP B 1054 REMARK 465 LEU B 1055 REMARK 465 SER B 1056 REMARK 465 ALA B 1057 REMARK 465 LEU B 1058 REMARK 465 ASN B 1059 REMARK 465 PRO B 1060 REMARK 465 GLU B 1061 REMARK 465 ASP B 1099 REMARK 465 ASN B 1100 REMARK 465 ASP B 1101 REMARK 465 GLY B 1102 REMARK 465 ARG B 1114 REMARK 465 ILE B 1115 REMARK 465 THR B 1116 REMARK 465 ASP B 1117 REMARK 465 ILE B 1118 REMARK 465 GLY B 1119 REMARK 465 SER B 1149 REMARK 465 GLU B 1150 REMARK 465 GLY B 1151 REMARK 465 VAL B 1237 REMARK 465 HIS B 1238 REMARK 465 ASN B 1239 REMARK 465 LYS B 1240 REMARK 465 THR B 1241 REMARK 465 GLY B 1242 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 SER A 1056 OG REMARK 480 GLU A 1061 CG CD OE1 OE2 REMARK 480 GLN A 1123 CD OE1 NE2 REMARK 480 GLN B 1123 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 1284 O HOH A 421 1.81 REMARK 500 N HIS A 1052 O HOH A 367 2.04 REMARK 500 ND1 HIS A 1174 O HOH A 349 2.08 REMARK 500 OD1 ASP A 1231 O HOH A 286 2.11 REMARK 500 O LYS B 1198 O HOH B 426 2.13 REMARK 500 O HOH B 119 O HOH B 144 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A1284 CE2 TYR A1284 CD2 -0.131 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A1184 CB - CG - CD2 ANGL. DEV. = 4.5 DEGREES REMARK 500 PHE A1184 CB - CG - CD1 ANGL. DEV. = -4.8 DEGREES REMARK 500 TYR A1284 CB - CG - CD2 ANGL. DEV. = -4.2 DEGREES REMARK 500 CYS A1319 CA - CB - SG ANGL. DEV. = 8.7 DEGREES REMARK 500 ARG B1166 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG B1166 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B1300 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A1116 -55.92 -120.60 REMARK 500 ARG A1203 -14.18 78.27 REMARK 500 ASP A1204 47.51 -141.08 REMARK 500 ALA A1221 -158.89 -128.75 REMARK 500 ARG B1203 -19.93 82.15 REMARK 500 ARG B1203 -10.81 80.52 REMARK 500 ASP B1204 48.30 -144.12 REMARK 500 ASP B1204 48.30 -146.19 REMARK 500 ALA B1221 -152.82 -124.32 REMARK 500 HIS B1348 -76.07 -145.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IHX A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBL A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBL A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBL A 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IHX B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBL B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBL B1350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 6 REMARK 999 REMARK 999 SEQUENCE REMARK 999 VAL TO LEU CONFLICT IN UNP DATABASE ENTRY P08581 DBREF 3F66 A 1052 1349 UNP P08581 MET_HUMAN 1052 1349 DBREF 3F66 B 1052 1349 UNP P08581 MET_HUMAN 1052 1349 SEQADV 3F66 LEU A 1272 UNP P08581 VAL 1272 SEE REMARK 999 SEQADV 3F66 LEU B 1272 UNP P08581 VAL 1272 SEE REMARK 999 SEQRES 1 A 298 HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL GLN SEQRES 2 A 298 ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU ILE SEQRES 3 A 298 VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY SEQRES 4 A 298 CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY LYS SEQRES 5 A 298 LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE THR SEQRES 6 A 298 ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY ILE SEQRES 7 A 298 ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER LEU SEQRES 8 A 298 LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU VAL SEQRES 9 A 298 VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN PHE SEQRES 10 A 298 ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP LEU SEQRES 11 A 298 ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS TYR SEQRES 12 A 298 LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA SEQRES 13 A 298 ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS VAL SEQRES 14 A 298 ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS GLU SEQRES 15 A 298 TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU PRO SEQRES 16 A 298 VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN LYS SEQRES 17 A 298 PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 18 A 298 LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR PRO SEQRES 19 A 298 ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU GLN SEQRES 20 A 298 GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO SEQRES 21 A 298 LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS ALA SEQRES 22 A 298 GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG ILE SEQRES 23 A 298 SER ALA ILE PHE SER THR PHE ILE GLY GLU HIS TYR SEQRES 1 B 298 HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL GLN SEQRES 2 B 298 ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU ILE SEQRES 3 B 298 VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY SEQRES 4 B 298 CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY LYS SEQRES 5 B 298 LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE THR SEQRES 6 B 298 ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY ILE SEQRES 7 B 298 ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER LEU SEQRES 8 B 298 LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU VAL SEQRES 9 B 298 VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN PHE SEQRES 10 B 298 ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP LEU SEQRES 11 B 298 ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS TYR SEQRES 12 B 298 LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA SEQRES 13 B 298 ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS VAL SEQRES 14 B 298 ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS GLU SEQRES 15 B 298 TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU PRO SEQRES 16 B 298 VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN LYS SEQRES 17 B 298 PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL LEU SEQRES 18 B 298 LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR PRO SEQRES 19 B 298 ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU GLN SEQRES 20 B 298 GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO SEQRES 21 B 298 LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS ALA SEQRES 22 B 298 GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG ILE SEQRES 23 B 298 SER ALA ILE PHE SER THR PHE ILE GLY GLU HIS TYR HET IHX A 1 28 HET GBL A 3 6 HET GBL A 4 6 HET GBL A 5 6 HET IHX B 2 28 HET GBL B 1 6 HET GBL B1350 6 HET NA B 6 1 HETNAM IHX 3-[3-(4-METHYLPIPERAZIN-1-YL)-7-(TRIFLUOROMETHYL) HETNAM 2 IHX QUINOXALIN-5-YL]PHENOL HETNAM GBL GAMMA-BUTYROLACTONE HETNAM NA SODIUM ION HETSYN GBL DIHYDROFURAN-2(3H)-ONE FORMUL 3 IHX 2(C20 H19 F3 N4 O) FORMUL 4 GBL 5(C4 H6 O2) FORMUL 10 NA NA 1+ FORMUL 11 HOH *453(H2 O) HELIX 1 1 ASP A 1054 LEU A 1058 5 5 HELIX 2 2 ASN A 1059 GLN A 1067 1 9 HELIX 3 3 HIS A 1068 VAL A 1070 5 3 HELIX 4 4 GLY A 1072 SER A 1074 5 3 HELIX 5 5 ASP A 1117 ASP A 1133 1 17 HELIX 6 6 ASP A 1164 ASN A 1171 1 8 HELIX 7 7 THR A 1177 LYS A 1198 1 22 HELIX 8 8 ALA A 1206 ARG A 1208 5 3 HELIX 9 9 PHE A 1223 ARG A 1227 5 5 HELIX 10 10 ASP A 1231 TYR A 1235 5 5 HELIX 11 11 PRO A 1246 MET A 1250 5 5 HELIX 12 12 ALA A 1251 GLN A 1258 1 8 HELIX 13 13 THR A 1261 THR A 1278 1 18 HELIX 14 14 ASP A 1291 GLN A 1298 1 8 HELIX 15 15 PRO A 1309 TRP A 1320 1 12 HELIX 16 16 LYS A 1323 ARG A 1327 5 5 HELIX 17 17 SER A 1329 THR A 1343 1 15 HELIX 18 18 LEU B 1062 GLN B 1067 1 6 HELIX 19 19 GLY B 1072 SER B 1074 5 3 HELIX 20 20 GLU B 1120 PHE B 1134 1 15 HELIX 21 21 ASP B 1164 ASN B 1171 1 8 HELIX 22 22 THR B 1177 LYS B 1198 1 22 HELIX 23 23 ALA B 1206 ARG B 1208 5 3 HELIX 24 24 PHE B 1223 ARG B 1227 5 5 HELIX 25 25 ASP B 1231 TYR B 1235 5 5 HELIX 26 26 PRO B 1246 MET B 1250 5 5 HELIX 27 27 ALA B 1251 GLN B 1258 1 8 HELIX 28 28 THR B 1261 THR B 1278 1 18 HELIX 29 29 ASN B 1288 PHE B 1290 5 3 HELIX 30 30 ASP B 1291 GLN B 1298 1 8 HELIX 31 31 PRO B 1309 TRP B 1320 1 12 HELIX 32 32 LYS B 1323 ARG B 1327 5 5 HELIX 33 33 SER B 1329 SER B 1342 1 14 SHEET 1 A 5 LEU A1076 GLY A1087 0 SHEET 2 A 5 GLY A1090 LEU A1097 -1 O VAL A1092 N GLY A1085 SHEET 3 A 5 ILE A1105 LEU A1112 -1 O VAL A1109 N TYR A1093 SHEET 4 A 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 A 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 B 2 CYS A1210 LEU A1212 0 SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 C 5 LEU B1076 ARG B1086 0 SHEET 2 C 5 CYS B1091 LEU B1097 -1 O THR B1096 N ILE B1077 SHEET 3 C 5 ILE B1105 SER B1111 -1 O ILE B1105 N LEU B1097 SHEET 4 C 5 LEU B1154 LEU B1157 -1 O LEU B1157 N ALA B1108 SHEET 5 C 5 GLY B1144 CYS B1146 -1 N GLY B1144 O VAL B1156 SHEET 1 D 2 CYS B1210 LEU B1212 0 SHEET 2 D 2 VAL B1218 VAL B1220 -1 O LYS B1219 N MET B1211 SITE 1 AC1 10 GBL A 3 HOH A 336 ILE A1084 ALA A1108 SITE 2 AC1 10 LEU A1140 LEU A1157 PRO A1158 TYR A1159 SITE 3 AC1 10 MET A1160 MET A1211 SITE 1 AC2 5 IHX A 1 ARG A1208 ALA A1221 ASP A1222 SITE 2 AC2 5 TYR A1230 SITE 1 AC3 6 MET A1131 LEU A1140 LEU A1142 PHE A1223 SITE 2 AC3 6 GLY A1224 LEU A1225 SITE 1 AC4 5 HOH A 339 PHE A1168 PRO A1176 ASP A1180 SITE 2 AC4 5 PHE A1184 SITE 1 AC5 10 GBL B 1 HOH B 342 ILE B1084 ALA B1108 SITE 2 AC5 10 LEU B1157 PRO B1158 TYR B1159 MET B1160 SITE 3 AC5 10 LYS B1161 MET B1211 SITE 1 AC6 5 IHX B 2 ARG B1208 ALA B1221 ASP B1222 SITE 2 AC6 5 TYR B1230 SITE 1 AC7 6 ASP B1180 GLY B1183 PHE B1184 GLN B1187 SITE 2 AC7 6 PHE B1341 TYR B1349 SITE 1 AC8 6 HOH B 155 HOH B 201 HOH B 280 HOH B 289 SITE 2 AC8 6 LYS B1132 PHE B1134 CRYST1 47.377 47.587 75.600 100.70 103.62 98.29 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021107 0.003077 0.005974 0.00000 SCALE2 0.000000 0.021236 0.004982 0.00000 SCALE3 0.000000 0.000000 0.013980 0.00000